By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Pharming Group N.V. 

P.O. Box 451

AL Leiden    2300  The Netherlands
Phone: 31-0-71-524-7400 Fax: +31-0-71-521-6507


SEARCH JOBS








Company News
Pharming Group (PHGUF.PK) Release: HAEi Global Access Program for RUCONEST Now Live 7/21/2015 12:15:39 PM
Pharming Group (PHGUF.PK) Announces Us$17 Million (€15.6 Million) Straight Debt Financing 7/20/2015 9:35:46 AM
Pharming Group (PHGUF.PK) Announces Interim Results From The Ongoing Phase II Pediatric Clinical Trial Of Ruconest 6/1/2015 10:04:47 AM
Pharming Group (PHGUF.PK) And Clinigen Group Initiate "Haei GAP" Global Access Program For RUCONEST 5/18/2015 9:41:38 AM
Pharming Group (PHGUF.PK) Reports On Financial Results For Q1 2015 4/30/2015 11:18:45 AM
Pharming Group (PHGUF.PK) Nominates Paul Sekhri And Jan Egberts As Members Of Its Board Of Supervisory Directors 3/19/2015 10:28:57 AM
Pharming Group (PHGUF.PK) Appoints Dr. Perry Calias As Chief Scientific Officer 2/18/2015 10:39:48 AM
Pharming Group (PHGUF.PK) And Salix Pharmaceuticals, Ltd. (SLXP) Announce First Patient Treated In Clinical Study Of Ruconest® For Prophylaxis Of Hereditary Angioedema 1/8/2015 10:42:34 AM
Pharming Group (PHGUF.PK) Confirms Receipt Of US$20 Million Milestone Payment From Salix Pharmaceuticals, Ltd. (SLXP) 11/4/2014 9:23:43 AM
Pharming Group (PHGUF.PK) And Salix Pharmaceuticals, Ltd. (SLXP) Announce The Launch Of Ruconest® In The U.S. For The Treatment Of Acute Angioedema Attacks In Patients With Hereditary Angioedema (HAE) 11/3/2014 10:33:25 AM
12345678910...
//-->